Trials / Completed
CompletedNCT00691535
Genetics of Symptomatology and Treatment Response in Psychotic Major Depression
Association of BDNF, COMT, MDRI, CRH, CRF, and GC Receptor Genetic Polymorphisms With Symptomatology and Treatment Response in Psychotic Major Depression
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (planned)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
We hope to learn more about the biology of psychiatric illness with the hope of improving the diagnosis and treatment of such psychiatric conditions as major depression.
Detailed description
From the blood sample you donate, the researchers will obtain DNA. This DNA will be used to search for DNA markers related to the underlying biology of psychiatric illness and how this might explain the symptoms of these disorders. Research using DNA is an important way to try to understand human disease and/or the role genes play in disease. In effect, part of your blood sample will be used to attempt to understand how genetic factors contribute to the symptoms of such psychiatric conditions as major depression.
Conditions
Timeline
- Start date
- 2003-10-01
- Primary completion
- 2012-06-01
- First posted
- 2008-06-05
- Last updated
- 2019-06-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00691535. Inclusion in this directory is not an endorsement.